Company Profile

Kroger Stock Price, News & Catalysts

Ticker:
KR
Exchange:
NYSE
Sector:
Biopharma
Location:
United States

Stock performance

56.07 USD (-1.09%)

Close

Last updated: August 17, 2026

38B USD

Market cap

Why the stock is moving

As of Aug 17, 2026, KR closed down 1.09% at $56.07. No new same-company headline was identified in the current news window.

Company overview

Business overview

Kroger is a grocery and consumer retail company with a large U.S. footprint and significant pharmacy and healthcare-adjacent operations. Its core business is retail food distribution, not biotechnology.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NYSE, Kroger has a broad national retail footprint. It sits in consumer retail and pharmacy services rather than biotech.

Business Model Characteristics

The company generates revenue through grocery retail, private label goods, and pharmacy operations. Investors watch same-store sales, margins, consumer demand, and pharmacy contribution rather than clinical or regulatory catalysts.

Position Within the Biotechnology Landscape

Kroger is not a biotech company, but its pharmacy business gives it some healthcare adjacency. It belongs in consumer retail, not the biotech or medtech stack.

Future catalysts

  • Kroger’s next catalysts are grocery margin, pharmacy execution, and e-commerce / digital fulfillment trends that affect the growth mix. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.

Recent news

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Kroger (KR)?

    Kroger (KR) most recently closed at 56.07 USD, a -1.09% move versus the previous session.

    What is the market cap of Kroger (KR)?

    Kroger currently has a market capitalization of 38B USD on BioPharmSignal.

    What does Kroger do?

    Kroger is a grocery and consumer retail company with a large U.S. footprint and significant pharmacy and healthcare-adjacent operations. Its core business is retail food distribution, not biotechnology.

    On which exchange is KR stock listed?

    Kroger (KR) is associated with NYSE, United States, Biopharma.

    What is Kroger?

    Kroger’s next catalysts are grocery margin, pharmacy execution, and e-commerce / digital fulfillment trends that affect the growth mix.

    Which conditions is Kroger targeting with Kroger?

    Kroger’s next catalysts are grocery margin, pharmacy execution, and e-commerce / digital fulfillment trends that affect the growth mix.

    How does Kroger describe recent progress with Kroger?

    Kroger’s next catalysts are grocery margin, pharmacy execution, and e-commerce / digital fulfillment trends that affect the growth mix.

    What future catalysts are investors watching for Kroger?

    Kroger’s next catalysts are grocery margin, pharmacy execution, and e-commerce / digital fulfillment trends that affect the growth mix. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone...